Company
Science
Products
Animals
메뉴를 선택하세요.
Contact Us
(R&D)Scientists
Patients-Farm Animal
Patients-Companion Animal
Medical Professionals
IR
News
Events
Report
Jobs
Jobs
Search
Search
Company
People
Milestones
Collaboration
Location
Science
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Pipeline
Animals
Farm Animal
Companion Animal
메뉴를 선택하세요.
Contact Us
(R&D)Scientists
Patients-Farm Animal
Patients-Companion Animal
Medical Professionals
IR
News
Events
Report
Jobs
Jobs
Search
Search
Company
People
Milestones
Collaboration
Location
Science
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Pipeline
Animals
Farm Animal
Companion Animal
Contact Us
(R&D)Scientists
Patients-Farm Animal
Patients-Companion Animal
Medical Professionals
IR
News
Events
Report
Jobs
Jobs
Search
Search
Company
People
Milestones
Collaboration
Location
Science
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Pipeline
Animals
Farm Animal
Companion Animal
CLOSE
R & D
Patients
Veterinarians
IR
Jobs
Company
People
Milestones
Collaboration
Location
Science
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Pipeline
Animals
Farm Animal
Companion Animal
News
> IR > News
News
Events
Report
제목
반려견 DNA면역항암제'PLS-D5000' 3상 계획 승인
작성자
관리자
등록일
22-03-25
조회수
4,284
반려견용 DNA면역항암제인 'PLS-D5000'의 임상 3상 계획을 농림축산검역본부가 승인했다.
이번 임상 3상에서 플럼라인생명과학은 PLS-D5000의 악성 림프종(혈액암)에 대한 효능 및 안전성을 확인하게 된다
http://m.thebell.co.kr/m/newsview.asp?svccode=00&newskey=202203241006130400108585
목록
공지사항
이전글
대웅제약·플럼라인·박셀바이오, 반려동물 전용 의약품 개발 봇물
공지사항
다음글
대웅펫과 반려견 혁신신약 독점판권 계약